Mill Creek Life Sciences provides tools and technologies to support the development and application of cellular and biologic therapeutics.
Mill Creek Life Sciences provides tools and technologies to support the development and application of cellular and biologic therapeutics. It involves in developing, licensing, and commercializing intellectual property, patents, and know-how related to the production of a cell culture supplement. The company develops products to supplement cell culture used in stem cells and primary cells for clinical and research markets. Its products include PLTMax, which is obtained using normal human donor platelets collected at the United States centers. Mill Creek Life Sciences, LLC was founded in 2010 and is based in Rochester, Minnesota.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 18, 2019 | Grant | $100K | 1 | Regenerative Medicine Minnesota | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Regenerative Medicine Minnesota | Yes | Grant |